The Impact of AIA Proceedings on the Life Sciences (RECORDING)
-
You must log in to register
- Non-member - $150
- Member - Free!
This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.
Ashita Doshi
IP Counsel Leader for IP Disputes
Thermo Fisher Scientific
Ashita Doshi is an IP Counsel Leader at Thermo Fisher Scientific, specializing in strategic patent dispute resolution, risk management and prosecution, with a focus on AIA patent challenges at the PTAB. Ashita obtained a Ph.D. in Molecular Biology at Tufts University and a J.D. from the University of California at Berkeley. She has successfully challenged about 20 patents asserted in four litigations through inter partes and ex parte reexamination, and five patents asserted in three litigations through inter partes review. She has extensive in-house experience in litigation support, freedom-to-operate analysis, strategic product design and clearance, patent drafting and prosecution. Her prior law firm experience includes providing non-infringement and invalidity opinions, freedom-to-operate assessments and patent landscaping; drafting and prosecuting applications; and supporting interferences, oppositions and litigations.
Emily Johnson
Head of IP Policy & Advocacy
Amgen, Inc.
Emily Johnson is the Head of IP Policy & Advocacy for Amgen, one of the world’s leading biotechnology companies. Emily is responsible for influencing the development of sound public policy with respect to IP protections that are important to Amgen’s long-term success. Emily collaborates cross-functionally with Amgen’s IP, litigation, regulatory, antitrust, commercial, and government affairs teams to develop IP policy positions. She also engages with external trade organizations and government agencies and identifies and develops amicus brief opportunities in cases that raise significant IP issues for Amgen. Prior to Emily’s policy role, she litigated U.S. and foreign patent disputes, proceedings before the USPTO’s Patent Trial and Appeal Board, and appeals to the Federal Circuit. Emily had the privilege of clerking for the Honorable Arthur Gajarsa (now retired) at the US Court of Appeals for the Federal Circuit. Emily chairs the Pharmaceutical & Biotechnology Issues Committee of Intellectual Property Owners Association and serves on the Board of the Federal Circuit Bar Association.
Philip Johnson
Chair, Steering Committee
Coalition for 21st Century Patent Reform
Phil Johnson is retired as Senior Vice President – Intellectual Property Policy & Strategy of Johnson & Johnson – Law Department. Prior to April of 2014, he was Senior Vice President and Chief Intellectual Property Counsel of Johnson & Johnson where he managed a worldwide group of about 270 IP professionals, of whom over 100 were patent and trademark attorneys. Before joining Johnson & Johnson in 2000, Phil was a senior partner and co-chair of IP litigation at Woodcock Washburn in Philadelphia. During his 27 years in private practice, Phil counseled independent inventors, startups, universities and businesses of all sizes in all aspects of intellectual property law. His diverse practice pertained to advances in a wide variety of technologies, including pharmaceuticals, diagnostics, medical devices, consumer products, semi-conductor fabrication, automated manufacturing, materials and waste management. During his time in private practice, Phil served as trial counsel in countless IP disputes, including cases resolved by arbitration, bench trials, jury trials and appeals to the Federal Circuit Court of Appeals, many of which resulted in reported decisions.
Todd Walters
Shareholder
Buchanan Ingersoll & Rooney PC
Todd Walters is the Chair of the firm’s Patent Office Litigation practice and Co-Chair of the Intellectual Property section. He is a current Vice-Chair of the Post-Grant Practice Committee of the Intellectual Property Owners Association (IPO), a past Chair of the Patent Trial and Appeal Board (PTAB) Trial Committee of the American Intellectual Property Law Association (AIPLA) and a past Chair of the USPTO Post Grant and Inter Partes Practice Committee of the American Bar Association-Intellectual Property Law (ABA-IPL) section. Todd was named the Best Lawyers ® 2020 Patent Law “Lawyer of the Year” in Washington, D.C.